We are delighted to share our important new open access article: In silico prediction of pharmaceutical degradation pathways: A benchmarking study using …
Throughout 2023, our dedicated team contributed significantly to various journals through authoring and co-authoring a plethora of publications. Here are the articles, …
2023 was another exciting year at Lhasa, and there is plenty to look forward to in 2024! For our first Lhasa blog …
Ensuring the safety and efficacy of active pharmaceutical ingredients (APIs) is of paramount importance. A critical aspect of this process involves the …
At Lhasa, we believe in the transformative power of knowledge sharing as the driving force to support the global challenge of nitrosamine …
Building on the success of our recent webinar, How to establish acceptable intake (AI) limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs), we’re …